Recent

% | $
Quotes you view appear here for quick access.

Neuralstem, Inc. Message Board

  • lowl22 lowl22 Oct 17, 2012 9:20 AM Flag

    If you like CUR you will love HBIO

    Real business earning 40 cents a share for instrument business and the following is from presentation on regenerative business
    • Regenerative Medicine Device (RMD) Business
    • Five patients already treated with regenerated tracheal transplants, clinical trial begun
    Copyright © Harvard Bioscience 2012
    Tools to Advance Life Science Research
    and Regenerative Medicine 4
    • Heart, lung, kidney and liver transplant bioreactors in research stage
    • Clinical stem cell injector syringe pump will be submitted for regulatory review this year
    • Investment stage business: 13c EPS investment in 2012. Exploring strategic alternatives for funding this
    at a higher level
    • We believe this nascent market could potentially grow to hundreds of millions of dollars annually

 
CUR
1.94-0.06(-3.00%)Apr 24 4:00 PMEDT